All Stories

Fierce Biotech Fundraising Tracker '25: Epicrispr claims $68M series B; Character clinches $93M

The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.

Mar 27, 2025 - 23:12
 0
Fierce Biotech Fundraising Tracker '25: Epicrispr claims $68M series B; Character clinches $93M
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.
Read More

Tags:

Previous Article

FDA clears first automated endoscope cleaning system with Nanosonics' CORIS

Next Article

Fierce Biotech Layoff Tracker 2025: Nkarta cuts 53 roles; ElevateBio trims team

Related Posts

Denali's ALS drug fails to redeem itself, missing key biomarker in trial extension

Denali's ALS drug fails to redeem itself, missing key b...

Mar 6, 2025  0

Nkarta lays off 3rd of staff, including CFO, to fund autoimmune CAR NK program

Nkarta lays off 3rd of staff, including CFO, to fund au...

Mar 27, 2025  0

Fierce Biotech Layoff Tracker 2025: Moderna lays off 50 employees; Kojin to close

Fierce Biotech Layoff Tracker 2025: Moderna lays off 50...

Feb 14, 2025  0